Results 151 to 160 of about 187,354 (214)
Survival Outcomes in ERBB2-Low vs ERBB2-Null Advanced Gastric Cancer.
Karaoglan BB +12 more
europepmc +1 more source
Dynamic HER2 reassessment and precision sequencing after trastuzumab in HER2-positive advanced gastric cancer. [PDF]
Ooki A, Shimozaki K, Yamaguchi K.
europepmc +1 more source
Early time-of-day infusion of PD-1 inhibitor improves prognosis in advanced gastric cancer: a multicenter real-world study. [PDF]
Qu Z +8 more
europepmc +1 more source
AI‐Driven Cancer Multi‐Omics: A Review From the Data Pipeline Perspective
The exponential growth of cancer multi‐omics data brings opportunities and challenges for precision oncology. This review systematically examines AI's role in addressing these challenges, covering generative models, integration architectures, Explainable AI for clinical trust, clinical applications, and key directions for clinical translation.
Shilong Liu, Shunxiang Li, Kun Qian
wiley +1 more source
This review aims to provide a broad understanding for interdisciplinary researchers in engineering and clinical applications. It addresses the development and control of magnetic actuation systems (MASs) in clinical surgeries and their revolutionary effects in multiple clinical applications.
Yingxin Huo +3 more
wiley +1 more source
Differential T cell clonal dynamics underlie outcomes to frontline chemoimmunotherapy in advanced gastric cancer. [PDF]
Wright SJ +16 more
europepmc +1 more source
Reconsidering the terminology of "early" and "advanced" gastric cancer: toward a harmonized global lexicon. [PDF]
Sano T, Boku N, Lordick F.
europepmc +1 more source
ABSTRACT Chromosomal abnormalities have a major clinical impact on hematological malignancies, particularly with regard to treatment strategies. To preserve and consolidate fundamental knowledge in this rapidly evolving field, the Francophone Group of Hematological Cytogenetics (Groupe Francophone de Cytogénétique Hématologique, GFCH) conducted a ...
Florence Nguyen‐Khac +16 more
wiley +1 more source
Efficacy of immune checkpoint inhibitor plus chemotherapy in ARID1A-mutated advanced gastric cancer. [PDF]
Shin JE, Lee E, Lim SH, Lee J, Kim ST.
europepmc +1 more source
Our study systematically explored the anti‐gastric cancer (GC) mechanism of Xanthotoxol (Xan), a natural active phytochemical, using an integrated strategy of network pharmacology, molecular simulation, and experimental validation. First, we identified 39 hub genes associated with gastric cancer using weighted gene co‐expression network analysis (WGCNA)
Yi Yang +10 more
wiley +1 more source

